- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03144414
Laparoscopic Assisted Doderlin Vaginal Hysterectomy
January 26, 2020 updated by: Mohamed S Sweed, MD, Ain Shams University
Laparoscopic Assisted Doderlin Vaginal Hysterectomy vs. Laparoscopic Assisted Vaginal Hysterectomy: A Randomized Clinical Trial.
This prospective randomized clinical trial will be conducted in Ain Shams University Maternity Hospital during the period from May 2017 to December 2017.
Group Ι: 30 patients will undergo conventional laparoscopic assisted vaginal hysterectomy (LAVH).
Group ΙΙ: 30 patients will undergo laparoscopic assisted Doderlein vaginal hysterectomy (LADH)
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Cairo, Egypt
- ain shams University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Age > 40 years.
- Uterine size ≤ 14weeks.
- Benign uterine pathology (Fibroid uterus, endometrial hyperplasia, DUB, uterine prolapse).
- No contraindication for laparoscopic surgery.
Exclusion Criteria:
- Gynecologic malignancy.
- Contraindications to laparoscopy like any medical condition worsened by pneumoperitoneum or the Trendelenburg position.
- Large abdominal hernia
- Large ovarian mass
- History of previous laparotomy finding extensive adhesions
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: LAVH
Laparoscopic Assisted Vaginal Hysterectomy
|
Laparoscopic hysterectomy
Other Names:
|
Active Comparator: LADH
Laparoscopic Assisted Doderlin Vaginal Hysterectomy
|
Laparoscopic hysterectomy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Operative time
Time Frame: 24 hours
|
24 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood loss
Time Frame: 24 hours
|
24 hours
|
|
postoperative pain
Time Frame: 24 hours
|
questionnaire using Visual Analogue scale
|
24 hours
|
operative complications
Time Frame: 24 hours
|
24 hours
|
|
Hospital stay
Time Frame: 24 hours
|
24 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 20, 2017
Primary Completion (Actual)
January 10, 2020
Study Completion (Actual)
January 20, 2020
Study Registration Dates
First Submitted
April 30, 2017
First Submitted That Met QC Criteria
May 5, 2017
First Posted (Actual)
May 8, 2017
Study Record Updates
Last Update Posted (Actual)
January 28, 2020
Last Update Submitted That Met QC Criteria
January 26, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- AS1393
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Laparoscopic Hysterectomy
-
ZSX Medical LLCTerminatedLaparoscopic HysterectomyUnited States
-
University of North Carolina, Chapel HillCompletedLaparoscopic HysterectomyUnited States
-
Balikesir UniversityCompleted
-
University of North Carolina, Chapel HillCompletedLaparoscopic Hysterectomy and/or Laparoscopic SacrocolpopexyUnited States
-
Samyang Biopharmaceuticals CorporationRecruitingLaparoscopic HysterectomyKorea, Republic of
-
ZSX Medical LLCEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingLaparoscopic HysterectomyUnited States
-
Danbury HospitalEthicon, Inc.Completed
-
Mansoura UniversityRecruitingTotal Laparoscopic HysterectomyEgypt
-
Ilsan Cha hospitalRecruitingTotal Laparoscopic HysterectomyKorea, Republic of
-
ZSX Medical LLCCompletedTotal Laparoscopic HysterectomyMexico
Clinical Trials on Laparoscopic hysterectomy
-
Medway NHS Foundation TrustJohnson & JohnsonUnknownBenign Disease of the UterusUnited Kingdom
-
University of PalermoNot yet recruiting
-
Brigham and Women's HospitalWithdrawnGynecologic DiseasesUnited States
-
Samsung Medical CenterUnknownUterine Adenomyosis | Uterine MyomaKorea, Republic of
-
University of Texas Southwestern Medical CenterCompletedEndometriosis | Pelvic Pain | Adenomyosis | Metrorrhagia | Pelvic Inflammatory Disease | Leiomyoma | MenorrhagiaUnited States
-
The Cleveland ClinicCompletedUterine Fibroids, Menorrhagia, EndometriosisUnited States
-
Mansoura UniversityCompleted
-
The Cleveland ClinicRecruitingVaginal Hysterectomy | Laparoscopic Supracervical HysterectomyUnited States
-
Lei LiRecruitingRecurrence | Uterine Cervical Neoplasms | Mortality | Laparotomy | Laparoscopy | SurvivalChina
-
Tampere University HospitalCompleted